RAC 0.97% $1.54 race oncology ltd

Ann: Race Develops Improved IV Formulation of Zantrene, page-13

  1. 195 Posts.
    lightbulb Created with Sketch. 30

    https://hotcopper.com.au/data/attachments/4710/4710190-b8d946467dcfffee5673df1013090e8f.jpg

    that is amazing ..making it easier to administer means making it more accessible to patients
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.